Search

Find exactly what you’re looking for.
Search

Service
Showing 21-38 of 38 results

Please join us for an upcoming tech M&A workshop, Selling Up Selling Out: Live in Minneapolis, organized by Corum Group at our offices on Wednesday, August 9th. Saul Ewing LLP is sponsoring the half-day conference, where you can hear from former CEOs and market experts as they cover valuations...

A recent opinion from the 3rd Circuit U.S. Court of Appeals confirmed what should be settled law: deathbed gifts made by personal check delivered before death but deposited after death remain part of the donor’s taxable estate and thus subject to estate tax. A lot of taxes, legal fees, and headache...

Saul Ewing LLP, a full-service national law firm, today announced that the firm was recognized as Band 1 for Private Wealth Law in Maryland in Chambers High Net Worth 2023. Additionally, Jeff Glaser, chair of the firm's Personal Wealth, Estates & Trusts Practice, was ranked as a Band 1 attorney...

The Fundamentals of Arbitration Are you dealing with a dispute and debating whether to resolve it through arbitration pursuant to an arbitration provision in the subject agreement? Are you considering adding an arbitration provision to your standard contracts? This webinar will provide you with the...

​The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...

Recent Cases Interpreting the Federal Arbitration Act: Badgerow v. Walters & More! Litigation Associate Stephanie Denker will join a panel and discuss important decisions impacting arbitration waivers, petitions to confirm arbitral awards under 9 U.S.C. §9 and petitions to vacate arbitral awards...

LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

Opportunity Zones offer potential benefits for your clients, but it's crucial to distinguish between good and bad investments. Delve into the intricacies of the Opportunity Zone program, compliance and reporting obligations involved in maintaining these investments, and tax benefits that are...

Jury selection begins in tax fraud trial against Trump Organization l ABCNL The Trump Organization has pleaded not guilty to the criminal tax fraud charges and the former president has dismissed the investigation as a "hoax."

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

(Washington, DC, July 21, 2021) – Earl Adams, Jr., co-chair of the firm’s Regulatory, Compliance and Government practice, and Managing Partner of the firm’s Washington, D.C. office, has been appointed by President Biden to serve as Chief Counsel to the Federal Motor Carrier Safety Administration (...

Candice Kline, a partner in Saul Ewing's bankruptcy practice, will be a moderator at Succession Planning for a Small Business – Part 2, presented by the ISBA Business Advice and Financial Planning Section, on June 21, 2022. Succession Planning for a Small Business – Part 2 Presented by the ISBA...

Candice Kline, a partner in Saul Ewing's bankruptcy practice, will be a moderator at Succession Planning for a Small Business – Part 1, presented by the ISBA Business Advice and Financial Planning Section, on June 17, 2022. Succession Planning for a Small Business – Part 1 Presented by the ISBA...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information
Contact us